For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 248 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2019
Kern LM, Rajan M, Pincus HA, Casalino LP, Stuard SS.  2019.  Health Care Fragmentation in Medicaid Managed Care vs. Fee-for-Service.. Popul Health Manag.
Gomez-Arteaga A, Mark TM, Guarneri D, Christos PJ, Gergis U, Greenberg JD, Hsu J, Mayer SA, Niesvizky R, Pearse RN et al..  2019.  High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.. Bone Marrow Transplant.
Gomez-Arteaga A, Mark TM, Guarneri D, Christos PJ, Gergis U, Greenberg JD, Hsu J, Mayer SA, Niesvizky R, Pearse RN et al..  2019.  High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.. Bone Marrow Transplant.
Scali ST, Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, Schermerhorn M, Beiles B, Szeberin Z, Eldrup N et al..  2019.  Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.. Circulation. 140(15):1285-1287.
Scali ST, Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, Schermerhorn M, Beiles B, Szeberin Z, Eldrup N et al..  2019.  Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.. Circulation. 140(15):1285-1287.
McIntire PJ, Zhong E, Patel A, Khani F, D'Alfonso TM, Chen Z, Shin SJ, Ginter PS.  2019.  Hotspot enumeration of CD8+ tumor-infiltrating lymphocytes using digital image analysis in triple-negative breast cancer yields consistent results.. Hum Pathol. 85:27-32.
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH et al..  2019.  Immediate outcomes in early life epilepsy: A contemporary account.. Epilepsy Behav. 97:44-50.
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH et al..  2019.  Immediate outcomes in early life epilepsy: A contemporary account.. Epilepsy Behav. 97:44-50.
Khullar D, Chokshi DA.  2019.  Immigrant Health, Value-Based Care, and Emergency Medicaid Reform.. JAMA. 321(10):928-929.
Baber JT, Mao J, Sedrakyan A, Connolly PH, Meltzer AJ.  2019.  Impact of provider characteristics on use of endovenous ablation procedures in Medicare beneficiaries.. J Vasc Surg Venous Lymphat Disord. 7(2):203-209.e1.
D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al..  2019.  Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.
Grossman LV, Creber RMMasterso, Benda NC, Wright D, Vawdrey DK, Ancker JS.  2019.  Interventions to increase patient portal use in vulnerable populations: a systematic review.. J Am Med Inform Assoc. 26(8-9):855-870.
Carlo AD, Jeng PJ, Bao Y, Unützer J.  2019.  The Learning Curve After Implementation of Collaborative Care in a State Mental Health Integration Program.. Psychiatr Serv. 70(2):139-142.
Kasabwala K, Patel N, Cricco-Lizza E, Shimpi AA, Weng S, Buchmann RM, Motanagh S, Wu Y, Banerjee S, Khani F et al..  2019.  The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.. Eur Urol Oncol. 2(2):135-140.
Veinot TC, Ancker JS, Cole-Lewis H, Mynatt ED, Parker AG, Siek KA, Mamykina L.  2019.  Leveling Up: On the Potential of Upstream Health Informatics Interventions to Enhance Health Equity.. Med Care. 57 Suppl 6 Suppl 2:S108-S114.
Baik D, Reading M, Jia H, Grossman LV, Creber RMasterson.  2019.  Measuring health status and symptom burden using a web-based mHealth application in patients with heart failure.. Eur J Cardiovasc Nurs. 18(4):325-331.
Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al..  2019.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.
Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al..  2019.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.
Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al..  2019.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.
Khullar D, Wolfson D, Casalino LP.  2019.  Patient-Centered Performance Metrics-Reply.. JAMA. 321(18):1829-1830.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.